(Q37671961)
Statements
1 reference
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. (English)
1 reference
S Noguchi
M Piccart
G Hortobagyi
A Perez
M Geberth
T Csoszi
E Chouinard
V Srimuninnimit
P Puttawibul
J Eakle
W Feng
H Bauly
M El-Hashimy
T Taran
H A Burris
10 March 2014
1 reference